Among them, two studies demonstrated that the outcome of combination antifungal therapy was better than that of monotherapy, one study showed a trend toward a better outcome, and the remaining two studies indicated that combination antifungal therapy had no additional advantage over monotherapy or that the response to monotherapy was better ( Garbati et al., 2012 ).
← all excerpts
Efficacy and safety of voriconazole and caspofungin for the treatment of invasive pulmonary aspergillosis in critically ill patients in China.
1
—
—